After 15 years of successive randomized, controlled trials, indications for transcatheter aortic
valve replacement (TAVR) are rapidly expanding. In the coming years, this procedure could …

Transcatheter aortic valve implantation (TAVI) has matured into a standard treatment option
for patients with severe symptomatic aortic valve stenosis (AS) across the whole spectrum of …

The “Guidelines on the Management of Valvular Heart Disease” were initially published as
the “Guidelines on Non-pharmacological Treatment of Valvular Heart Disease” in 2002 …

Background Bicuspid aortic stenosis accounts for almost 50% of patients undergoing
surgical aortic valve replacement in the younger patients. Expanding the indication of …

Background: Limited information exists describing the results of transcatheter aortic valve
(TAV) replacement in patients with bicuspid aortic valve (BAV) disease (TAV-in-BAV) …

Background: Sizing for transcatheter aortic valve implantation in bicuspid aortic valves (BAV)
remains controversial. Methods and Results: The aim of the BAVARD (Bicuspid Aortic Valve …

Objectives: This study sought to evaluate transcatheter aortic valve replacement (TAVR) in
bicuspid aortic valve (BAV) aortic stenosis (AS), with a particular emphasis on TAVR …

Indications for transcatheter aortic valve implantation (TAVI) have expanded in many
countries to include patients with aortic stenosis who are at low surgical risk, and a similar …

Objectives: This study evaluated the results of transcatheter aortic valve replacement (TAVR)
in bicuspid aortic stenosis (AS) using a new-generation TAVR device. Background: A …

Objectives The aim of this study was to compare the feasibility, safety, and clinical outcomes
of transcatheter aortic valve replacement (TAVR) in bicuspid aortic valve (BAV) versus …